FDA Approves Boston Scientific’s Ingenio Pacemaker

May 8, 2012
Boston Scientific has won FDA approval for a new pacemaker platform the company hopes will revive excitement for the medical device company’s struggling cardiac rhythm management business. The new product, called Ingenio, launched in Europe last month, after regulatory approval there. It will launch immediately in the U.S.
Mass High Tech